Article info

Download PDFPDF

Response to: ‘Will SPAR be useful in the usual patients with scleroderma?’ by Chattopadhyay et al
Free

Authors

  1. Correspondence to Dr Oliver Distler, Department of Rheumatology, University Hospital Zurich, Zürich 8091, Switzerland; oliver.distler{at}usz.ch
View Full Text

Citation

Wu W, Jordan S, Distler O
Response to: ‘Will SPAR be useful in the usual patients with scleroderma?’ by Chattopadhyay et al

Publication history

  • Received October 15, 2018
  • Revised October 29, 2018
  • Accepted October 30, 2018
  • First published November 10, 2018.
Online issue publication 
October 15, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.